home pie left home pie right

Patient-Centered, Continuous Care.

Patients are placing new expectations on health systems for greater care personalization. Our model of continuous care delivers, with no added burden to patients or the health care system.

Doctor sitting down with a patient

Their Devices. Their Care Team.

Platform insights are informed by the member’s ecosytem. The platform products connect with 300+ consumer wearable devices and 940+ health systems and pharmacies.

arrow 1 new arrow 2 new arrow 3 new
dc globe

Lifestyle &
Clinical Data

GettyImages 1055015208
Group 3
1 GettyImages 891806504
Group 5
Group 4
meter
GettyImages 1213961430

Member
Insights

Clinicians &
Care Teams

right img
arrow 4 new

A Remote Care Model that Supports the Patient Journey.

Flexible Integration Approach.

Access a flexible, scalable, easy-to-use platform that supports multiple chronic conditions and can integrate with your current systems through technology partnerships.
Cluster of logos
BlueStar Health Systems on smart device

Access Patient Health Data.

Real-time care coordination requires real-time patient health data. Access patient information and recommended treatment modifications based on actual health trends and patterns. Get patient SMART Visit Reports containing clinical decision support for more productive care team visits.

Close Gaps In Care.

Proactively address gaps in care, care transitions and readmissions, and gain deeper insights into how patients are doing.

Caps in care statistics
Open macbook with BlueStar website

Achieve Better Population Health Insights.

The ability to collect and analyze patient health data allows providers to better coordinate care and support people throughout their care journeys.

CMS Reimbursement for Remote Patient Monitoring.

As an FDA-cleared Software as a Medical Device (SaMD) for type 1 and type 2 diabetes, BlueStar is reimbursable by CMS for RPM services while allowing patients to use whatever hardware device they choose.

Person holding phone with bluestar app
Clinical and Economic Analysis in
Type 2 Diabetes.
Whitepaper

12-Month Clinical Trial

In a prospective, randomized, controlled study, Quinn et al. (Diabetes Care, 2011) found that, individuals with type 2 diabetes whose A1C levels were > 7.5% at the time of enrollment, and who were randomized to use a mobile phone app to help them manage their diabetes in addition to usual care, improved A1C by an average 1.9%. Persons randomized to usual care alone improved A1C by an average of 0.7%. The difference between the intervention group and the control group was 1.2% (P < 0.001) over 12 months.
Methodology-Primary endpoint: change in A1C over one year. Randomization to one of four groups: (1) usual care (n=56), (2) usual care plus patient mobile app/access to web portal for diabetes management (n=23), (3) usual care, mobile app/portal for patient, plus provider access to raw patient data (n=22), and (4) usual care, mobile app/portal for patient, plus patient data tied to decision support for their physician (n=62). 213 patients enrolled; 163 included in the analysis. Limitations- Private insurance only. Study dropout rates required use of mixed-effects statistical modeling to impute missing observations
Reduction in Glycated hemoglobin A1C chart

The impact of A1C Reduction on Cost Savings.

Study Set Up

Welldoc funded a retrospective analysis with IBM Watson Health to test the relationship between A1C reduction and cost savings.

DATA INPUTS

IBM Watson Health was provided starting and ending A1C data from 3,000+ BlueStar users with type 2 diabetes.

STUDY POPULATION

IBM Watson Health ran user data through their MarketScan Database, which captures claims data of more than 200 million individuals in the US.
Cost savings chart
Medical Expenditures Correlated with A1C Reduction.
Ambulance icon
Hospitalizations, ER visits, and HCP office visits
Meds icon
Cost of medical devices, supplies, and medications
Heart icon
Cost of comorbid conditions (hypertension, weight, etc.)
Reach At-Risk Populations. At Scale.
Scale up to address the health conditions of the most vulnerable populations, while enabling care teams to have direct communication with those most in need of intervention.
Pyramid of risk
Net promoter score

Drive Engagement and Satisfaction with Your Patients.

With increased consumerization in healthcare, organizations benefit from improving the patient experience. Let us boost your numbers.

Man smiling at smartphone
Are You Ready to Empower Your Patients?
News Update: Welldoc Receives Ninth 510(k) for Award-Winning Diabetes Platform, BlueStar®